MUC16 and metastatic malignant neoplasm in the lymph nodes: Univariate analyses indicated that elevated serum CA125 and CA19-9 were statistically significant risk predictors for poor OS and RFS (Figures 2 and 3) in overall and nonelevated bilirubin patients, in addition to high TNM stage, lymph node metastasis, and chemotherapy.